登录 注册 会员服务 联系我们

A small molecule Inauhzin inhibits SIRT1 activity and suppresses tumour growth through activation of p53

  • Published:2012-02-13 Issue:4 Volume:4 Page:298-312
  • ISSN:1757-4676
  • Container-title:EMBO Molecular Medicine
  • language:en
  • Short-container-title:EMBO Mol Med

Author:

Zhang Qi12,Zeng Shelya X.12,Zhang Yu23,Zhang Yiwei12,Ding Derong2,Ye Qizhuang2,Meroueh Samy O.2,Lu Hua12

Affiliation:

1. Department of Biochemistry & Molecular Biology and Cancer Center, Tulane University School of Medicine, Louisiana, LA, USA

2. Department of Biochemistry & Molecular Biology, Indiana University School of Medicine‐Simon Cancer Center, Indianapolis, IN, USA

3. Department of Obstetrics and Gynecology, Xiangya Hospital, Central South University, Hunan, China

Publisher

EMBO

Subject

Molecular Medicine

Cited by 95 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SIRT1: a novel regulator in colorectal cancer;Biomedicine & Pharmacotherapy;2024-09

2. Activation and inhibition of sirtuins: From bench to bedside;Medicinal Research Reviews;2024-08-31

3. Sirtuin insights: bridging the gap between cellular processes and therapeutic applications;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-07-08

4. Mutant p53 reactivators protect breast cancer cells from ferroptosis;Cell Biochemistry and Function;2024-05-22

5. Boosting regulatory T cell-dependent immune tolerance by activation of p53;International Immunopharmacology;2023-12
同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3